Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10664 | 31245932 | Obesity (Silver Spring) | Association Between Nonalcoholic Fatty Liver Disease and Future Deterioration of Metabolic Health: A Cohort Study. | 2019 | Details |
| A10667 | 31245168 | Liver Res | Hepatic lipid homeostasis by peroxisome proliferator-activated receptor gamma 2. | 2018 | Details |
| A10668 | 31244779 | Front Endocrinol (Lausanne) | Liver and Steroid Hormones-Can a Touch of p53 Make a Difference? | 2019 | Details |
| A10669 | 31244392 | Biosci Biotechnol Biochem | Extracts of bilberry (Vaccinium myrtillus L.) fruits improve liver steatosis and injury in mice by preventing lipid accumulation and cell death. | 2019 | Details |
| A10670 | 31244307 | Asian Pac J Cancer Prev | Significance of Serum Adiponectin and Insulin Resistance Levels in Diagnosis of Egyptian Patients with Chronic Liver Disease and HCC. | 2019 | Details |
| A10671 | 31243878 | J Viral Hepat | Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response. | 2019 | Details |
| A10672 | 31243652 | Endocrine | Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis. | 2019 | Details |
| A10673 | 31242974 | Biochem Biophys Res Commun | Cordycepin alleviates hepatic lipid accumulation by inducing protective autophagy via PKA/mTOR pathway. | 2019 | Details |
| A10674 | 31241820 | Liver Int | Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs. | 2019 | Details |
| A10675 | 31241693 | Rev Paul Pediatr | PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS. | 2019 | Details |
| A10676 | 31241045 | Gen Physiol Biophys | Effect of glucagon-like peptide-1 analogue liraglutide on primary cultures of rat hepatocytes isolated from lean and steatotic livers. | 2019 | Details |
| A10677 | 31240043 | Acad Forensic Pathol | Fatty Liver and the Forensic Pathologist. | 2018 | Details |
| A10678 | 31239664 | Int J Nanomedicine | Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis. | 2019 | Details |
| A10679 | 31239155 | Biochem Biophys Res Commun | LncRNA NEAT1-MicroRNA-140 axis exacerbates nonalcoholic fatty liver through interrupting AMPK/SREBP-1 signaling. | 2019 | Details |
| A10680 | 31238892 | BMC Cancer | Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study. | 2019 | Details |
| A10683 | 31237317 | J Frailty Aging | Relationship between Grip Strength and Nonalcoholic Fatty Liver Disease in Men Living with HIV Referred to a Metabolic Clinic. | 2019 | Details |
| A10684 | 31236937 | Australas J Dermatol | Nonalcoholic fatty liver disease puts patients with psoriasis at greater cardiovascular risk. | 2019 | Details |
| A10685 | 31236880 | Bull Exp Biol Med | Effect of Linagliptin on the Ratio of Apoptosis Regulators in the Model of Non-Alcoholic Fatty Liver Disease in db/db Mice. | 2019 | Details |
| A10686 | 31236687 | Handb Exp Pharmacol | Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease. | 2019 | Details |
| A10687 | 31236111 | Int J Endocrinol | Liraglutide Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism via SHP1/AMPK Signaling Pathway. | 2019 | Details |
| A10688 | 31235168 | Diabetes Metab Syndr | Efficacy of a non-invasive model in predicting the cardiovascular morbidity and histological severity in non-alcoholic fatty liver disease. | 2019 | Details |
| A10689 | 31235166 | Diabetes Metab Syndr | A narrative review on effects of vitamin D on main risk factors and severity of Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10690 | 31235161 | Diabetes Metab Syndr | Serum Ferritin level, microalbuminuria and non-alcoholic fatty liver disease in type 2 diabetic patients. | 2019 | Details |
| A10691 | 31235092 | Diabetes Metab Syndr | Study of relationship between total vitamin D level and NAFLD in a sample of Egyptian patients with and without T2DM. | 2019 | Details |
| A10692 | 31234658 | Free Radic Res | Oxidative stress biomarkers in the serum and plasma of patients with non-alcoholic fatty liver disease (NAFLD). Can plasma AGE be a marker of NAFLD? Oxidative stress biomarkers in NAFLD patients. | 2019 | Details |
| A10693 | 31234281 | Int J Environ Res Public Health | Consumption of Sugar-Sweetened Beverages Has a Dose-Dependent Effect on the Risk of Non-Alcoholic Fatty Liver Disease: An Updated Systematic Review and Dose-Response Meta-Analysis. | 2019 | Details |
| A10695 | 31233775 | J Control Release | The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease. | 2019 | Details |
| A10696 | 31233751 | Eur J Pharmacol | Zoledronic acid prevents the hepatic changes associated with high fat diet in rats; the potential role of mevalonic acid pathway in nonalcoholic steatohepatitis. | 2019 | Details |
| A10697 | 31233672 | Eur J Neurol | Favorable impact of non-alcoholic fatty liver disease on the cerebral white matter hyperintensity in a neurologically healthy population. | 2019 | Details |
| A10698 | 31233523 | PLoS One | Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden mice. | 2019 | Details |
| A10699 | 31233505 | PLoS One | Adenovirus-mediated expression of SIK1 improves hepatic glucose and lipid metabolism in type 2 diabetes mellitus rats. | 2019 | Details |
| A10700 | 31232044 | Clin Lab | Association between Serum Ferritin Level and Nonalcoholic Fatty Liver Disease in a Non-Obese Chinese Population: a Cross-Sectional Study. | 2019 | Details |
| A10701 | 31230380 | Hepatology | The Role of Senescence in the Development of Nonalcoholic Fatty Liver Disease and Progression to Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10702 | 31230225 | Endocrine | Copeptin relates to a fatty liver and measures of obesity in a South African population with mixed ethnicities. | 2019 | Details |
| A10705 | 31228640 | Prog Neuropsychopharmacol Biol Psychiatry | Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patients. | 2019 | Details |
| A10706 | 31228267 | Med Phys | Fully automatic liver attenuation estimation combing CNN segmentation and morphological operations. | 2019 | Details |
| A10707 | 31227825 | Hum Mol Genet | Recent advances in novel therapies for lipid disorders. | 2019 | Details |
| A10708 | 31227533 | BMJ Open | Fatty liver and mortality: a cohort population study in South Italy. | 2019 | Details |
| A10710 | 31227231 | Mol Cell | HCF-1 Regulates De Novo Lipogenesis through a Nutrient-Sensitive Complex with ChREBP. | 2019 | Details |
| A10711 | 31226595 | J Hazard Mater | Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice. | 2019 | Details |
| A10712 | 31226399 | Free Radic Biol Med | Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway. | 2019 | Details |
| A10713 | 31226232 | Liver Int | Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non-alcoholic fatty liver disease. | 2019 | Details |
| A10716 | 31225503 | Cell Stress | Hepatic stress associated with pathologies characterized by disturbed glucose production. | 2019 | Details |
| A10717 | 31225483 | Cell Stress | Foie gras and liver regeneration: a fat dilemma. | 2018 | Details |
| A10718 | 31225456 | Cell Stress | Attenuating MKRN1 E3 ligase-mediated AMPKα suppression increases tolerance against metabolic stresses in mice. | 2018 | Details |
| A10719 | 31223344 | Diabetol Metab Syndr | Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study. | 2019 | Details |
| A10720 | 31222979 | J Cell Mol Med | Hepatic functional and pathological changes of type 1 diabetic mice in growing and maturation time. | 2019 | Details |
| A10721 | 31222786 | J Ultrasound Med | Application of Deep Learning in Quantitative Analysis of 2-Dimensional Ultrasound Imaging of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10722 | 31222048 | Nat Commun | Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis. | 2019 | Details |
| A10723 | 31221701 | Diabetes Care | Use of Plasma Fragments of Propeptides of Type III, V, and VI Procollagen for the Detection of Liver Fibrosis in Type 2 Diabetes. | 2019 | Details |
| A10725 | 31220177 | PLoS One | Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice. | 2019 | Details |
| A10726 | 31219825 | Curr Opin Clin Nutr Metab Care | Microbiota and nonalcoholic fatty liver disease: promising prospects for clinical interventions? | 2019 | Details |
| A10727 | 31219667 | Hepatol Res | Assessing the risk of hepatocellular carcinoma by combining liver stiffness and the controlled attenuation parameter. | 2019 | Details |
| A10728 | 31219486 | Saudi Med J | Position statement on the diagnosis and management of non-alcoholic fatty liver disease. | 2019 | Details |
| A10729 | 31219362 | Infect Dis (Lond) | Improvement in liver steatosis after the switch from a ritonavir-boosted protease inhibitor to raltegravir in HIV-infected patients with non-alcoholic fatty liver disease. | 2019 | Details |
| A10730 | 31219225 | Obesity (Silver Spring) | Genome-Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium. | 2019 | Details |
| A10731 | 31219051 | JMIR Res Protoc | Diet-Induced Alteration of Microbiota and Development of Obesity, Nonalcoholic Fatty Liver Disease, and Diabetes: Study Protocol of a Prospective Study. | 2019 | Details |
| A10732 | 31217846 | Am J Transl Res | Berberine prevents non-alcoholic steatohepatitis-derived hepatocellular carcinoma by inhibiting inflammation and angiogenesis in mice. | 2019 | Details |
| A10733 | 31217465 | Sci Rep | Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10734 | 31216433 | J Ethnopharmacol | Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice. | 2019 | Details |
| A10735 | 31216264 | J Pediatr Endocrinol Metab | Genetic polymorphisms associated with obesity and non-alcoholic fatty liver disease in Asian Indian adolescents. | 2019 | Details |
| A10736 | 31215672 | Hepatology | Sestrin 3 Protects Against Diet-Induced Nonalcoholic Steatohepatitis in Mice Through Suppression of Transforming Growth Factor β Signal Transduction. | 2019 | Details |
| A10737 | 31215394 | Mol Med | FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease. | 2019 | Details |
| A10738 | 31215262 | Expert Rev Gastroenterol Hepatol | Olive oil antioxidants and non-alcoholic fatty liver disease. | 2019 | Details |
| A10739 | 31214287 | Nutr Res Pract | Free fatty acid-induced histone acetyltransferase activity accelerates lipid accumulation in HepG2 cells. | 2019 | Details |
| A10740 | 31214277 | Oxid Med Cell Longev | TNFα-Mediated Necroptosis Aggravates Ischemia-Reperfusion Injury in the Fatty Liver by Regulating the Inflammatory Response. | 2019 | Details |
| A10741 | 31214196 | Front Immunol | Retained NK Cell Phenotype and Functionality in Non-alcoholic Fatty Liver Disease. | 2019 | Details |
| A10742 | 31214115 | Front Endocrinol (Lausanne) | Hepatic DNA Damage Induced by Electronic Cigarette Exposure Is Associated With the Modulation of NAD+/PARP1/SIRT1 Axis. | 2019 | Details |
| A10743 | 31214028 | Front Pharmacol | Prediction of VEGF-C as a Key Target of Pure Total Flavonoids From Citrus Against NAFLD in Mice via Network Pharmacology. | 2019 | Details |
| A10744 | 31213868 | Diabetes Metab Syndr Obes | The negative and detrimental effects of high fructose on the liver, with special reference to metabolic disorders. | 2019 | Details |
| A10746 | 31213030 | J Clin Med | A Systematic Review of NAFLD-Associated Extrahepatic Disorders in Youths. | 2019 | Details |
| A10747 | 31212642 | Int J Mol Sci | NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management. | 2019 | Details |
| A10748 | 31212314 | J Nutr | Dietary β-Cryptoxanthin Inhibits High-Refined Carbohydrate Diet-Induced Fatty Liver via Differential Protective Mechanisms Depending on Carotenoid Cleavage Enzymes in Male Mice. | 2019 | Details |
| A10749 | 31211621 | Am J Physiol Endocrinol Metab | Mouse trefoil factor 3 ameliorated high-fat-diet-induced hepatic steatosis via increasing peroxisome proliferator-activated receptor-α-mediated fatty acid oxidation. | 2019 | Details |
| A10750 | 31211018 | PeerJ | Impact of body weight gain on hepatic metabolism and hepatic inflammatory cytokines in comparison of Shetland pony geldings and Warmblood horse geldings. | 2019 | Details |
| A10751 | 31210034 | Diabetes Metab J | Understanding Bile Acid Signaling in Diabetes: From Pathophysiology to Therapeutic Targets. | 2019 | Details |
| A10752 | 31209928 | J Hum Nutr Diet | Prospective study of perceived dietary salt intake and the risk of non-alcoholic fatty liver disease. | 2019 | Details |
| A10753 | 31209721 | Dig Dis Sci | Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension. | 2019 | Details |
| A10754 | 31209199 | Cell Death Dis | Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis. | 2019 | Details |
| A10755 | 31208414 | Cardiovasc Diabetol | New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence. | 2019 | Details |
| A10756 | 31208147 | Nutrients | Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases. | 2019 | Details |
| A10757 | 31208043 | Nutrients | Dietary Fiber in Bilberry Ameliorates Pre-Obesity Events in Rats by Regulating Lipid Depot, Cecal Short-Chain Fatty Acid Formation and Microbiota Composition. | 2019 | Details |
| A10758 | 31207986 | J Clin Med | Effect of Short Term Intensive Lifestyle Intervention on Hepatic Steatosis Indexes in Adults with Obesity and/or Type 2 Diabetes. | 2019 | Details |
| A10759 | 31207429 | Pharmacol Rep | Protection against nonalcoholic steatohepatitis through targeting IL-18 and IL-1alpha by luteolin. | 2019 | Details |
| A10760 | 31206765 | Echocardiography | Evaluation of left atrial function in type 2 diabetes mellitus patients with nonalcoholic fatty liver disease by two-dimensional speckle tracking echocardiography. | 2019 | Details |
| A10761 | 31206703 | J Physiol | Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance. | 2019 | Details |
| A10762 | 31205454 | Dose Response | Inflammatory Effects of Subacute Exposure of Roundup in Rat Liver and Adipose Tissue. | 2019 | Details |
| A10763 | 31204416 | J Gastrointestin Liver Dis | Effect of Phytosomal Curcumin on Circulating Levels of Adiponectin and Leptin in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | 2019 | Details |
| A10764 | 31204398 | J Gastrointestin Liver Dis | Sleep Quality Associated with the Onset of NAFLD: Suggested Hypotheses. | 2019 | Details |
| A10765 | 31204306 | Obes Res Clin Pract | Neighbourhood socioeconomic circumstances, adiposity and cardiometabolic risk measures in children with severe obesity. | 2019 | Details |
| A10766 | 31204247 | Surg Obes Relat Dis | Validation of biochemical scores for liver steatosis before and 1 year after sleeve gastrectomy. | 2019 | Details |
| A10767 | 31203627 | J Agric Food Chem | Polyphenol-Rich Loquat Fruit Extract Prevents Fructose-Induced Nonalcoholic Fatty Liver Disease by Modulating Glycometabolism, Lipometabolism, Oxidative Stress, Inflammation, Intestinal Barrier, and Gut Microbiota in Mice. | 2019 | Details |
| A10768 | 31203554 | Dig Dis Sci | Efficacy of Probiotics and Synbiotics in Patients with Nonalcoholic Fatty Liver Disease: A Meta-Analysis. | 2019 | Details |
| A10769 | 31202833 | Metabolism | Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. | 2019 | Details |
| A10770 | 31202118 | J Nutr Biochem | Cyp2b-null male mice are susceptible to diet-induced obesity and perturbations in lipid homeostasis. | 2019 | Details |
| A10772 | 31201553 | Handb Exp Pharmacol | Pharmacologic Modulation of Bile Acid-FXR-FGF15/FGF19 Pathway for the Treatment of Nonalcoholic Steatohepatitis. | 2019 | Details |
| A10773 | 31199058 | Mol Nutr Food Res | Mitochondria-Mediated Pathogenesis and Therapeutics for Non-Alcoholic Fatty Liver Disease. | 2019 | Details |
| A10774 | 31199045 | Liver Int | Total liver phosphatidylcholine content associates with non-alcoholic steatohepatitis and glycine N-methyltransferase expression. | 2019 | Details |
| A10775 | 31197983 | J Korean Med Sci | Usefulness of Transient Elastography for Non-Invasive Diagnosis of Liver Fibrosis in Pediatric Non-Alcoholic Steatohepatitis. | 2019 | Details |
| A10776 | 31197565 | Handb Exp Pharmacol | Nonsteroidal FXR Ligands: Current Status and Clinical Applications. | 2019 | Details |